Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT07167277

The Impact of Whey Protein on Frailty in Older Adults Classified as Pre-frail

This pilot study aims to determine the impact of whey protein supplementation on brain antioxidant levels and to assess the effects of whey protein supplementation on physical function, body composition, and cognition in pre-frail older adults.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Notify Me

Key information

Age range

65 year–85 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

The University of Kansas Medical Center

Kansas City, Kansas, 66160, United States

About this study

Frailty is characterized by weakness, muscle loss, and physical impairment. It is suggested that long term oxidative stress might contribute to frailty. Glutathione (GSH), an antioxidant in cells, is needed to combat oxidative stress. Whey protein has the potential to increase brain antioxidant (GSH) levels by aiding in antioxidant synthesis. Frail older adults under-consume protein compared to healthy older adults.

Researchers want to see if supplementing with whey protein will improve brain antioxidant status in pre-frail older adults. They will measure this by using special Magnetic Resonance Imaging (MRI) scans.

Participants will be asked to complete a total of 4 study visits, all taking place on the University of Kansas Medical Center (KUMC) main campus. Two of these visits will include an MRI scan. Participation will last about 3 months.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Pre-frail according to Fried's phenotype
  • Age 65 to 85
  • Speak English as primary language and able to read and write in English
  • Stable medication for ≥ 30 days
  • Not already taking whey protein over the past 30 days

Exclusion criteria

  • Acute or chronic kidney disease
  • Recent major health concerns
  • Insulin-requiring diabetes
  • Cancer requiring chemotherapy or radiation within the past 5 years
  • Cardiac event (i.e., MI, etc.) in the past year
  • Dementia or neurodegenerative disease
  • Clinical trial or investigational drug or therapy participation within 30 days of the screening visit or during enrollment in the current study
  • MRI contraindications (pacemaker, aneurysm clips, artificial heart valves, metal fragments, foreign objects or claustrophobia)
  • Dairy Allergy or excluding dairy from diet for other reasons
  • Weight > 350 lbs.
  • The presence of major psychiatric disorders within the past 3 years including depression, anxiety, and alcohol (over 3 drinks/day or a total of 18 drinks/week) or drug abuse.

Treatment and study plan

Whey Protein

Dietary Supplement

24g of whey protein will be given to the participant to be consumed daily. Participants will be asked to consume 1 serving per day for 3 months.

Placebo

Dietary Supplement

A calorie matched serving of carbohydrate powder will be given to participants to consume daily. Participants will be asked to consume 1 serving per day for 3 months.

Primary outcomes

  1. Change in brain glutathione (GSH) levels measured using MRI scans.

    Time frame: Changes from baseline to 3 months.

    Brain GSH levels will be measured using 3T MRI scans.

Secondary outcomes

  1. Assess the change in physical function by measuring balance resistance, sit-to-stand, muscle strength and performance.

    Time frame: Changes from baseline to 3 months.

    Balance resistance will be measured with a pressure-sensitive walkway. Sit-to-stand will be measured by number of repetitions in 30 seconds and the time to complete 5 repetitions. Muscle strength and performance will be measured by grip strength and gait speed. Grip strength is measured 3 times and averaged. Gait speed is measured with a 15-foot walk test and will be measured twice.

  2. Assess body composition with a bioelectrical impedance analysis (BIA) device.

    Time frame: Changes from baseline to 3 months.

    To measure, subjects will stand on the device, covering the electrodes with their hands and feet. The measure takes less than 2 minutes.

  3. Assess cognition using the NIH Toolbox cognition battery.

    Time frame: Changes from baseline to 3 months.

    The NIH Toolbox cognition battery will include 5 tests resulting in a composite score. The exam will be administered on an iPad device.

Sponsors and collaborators

Lead sponsor

University of Kansas Medical Center

Other

Registry information

Official study title

Impact of Whey Protein on Frailty - a Pilot Study

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Sep 11, 2025
Registry last updated
May 14, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.